Impact of different palliative systemic treatments on skeletal muscle mass in metastatic colorectal cancer patients

BACKGROUND: Observational studies suggest that loss of skeletal muscle mass (SMM) is associated with chemotherapy‐related toxicity, poor quality of life, and poor survival in metastatic colorectal cancer (mCRC) patients. Little is known about the evolution of SMM during palliative systemic therapy....

Descripción completa

Detalles Bibliográficos
Autores principales: Kurk, Sophie A., Peeters, Petra H.M., Dorresteijn, Bram, de Jong, Pim A., Jourdan, Marion, Kuijf, Hugo J., Punt, Cornelis J.A., Koopman, Miriam, May, Anne M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204584/
https://www.ncbi.nlm.nih.gov/pubmed/30144305
http://dx.doi.org/10.1002/jcsm.12337

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204584/
https://www.ncbi.nlm.nih.gov/pubmed/30144305
http://dx.doi.org/10.1002/jcsm.12337

Ejemplares similares